Tolera Therapeutics, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals
See more in Biomedtracker

Latest on Tolera Therapeutics, Inc.

Scrip

Celiac Research Partnership Builds Takeda’s GI Interests

 
• By Ian Haydock

Takeda Pharmaceutical Co. Ltd. has already said that it sees gastroenterology and gastrointestinal therapies as core interests for its commercial and research portfolio, and the top Japanese pharma

Scrip

Recent Financings of Private Companies, November 2012

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS Aushon BioSystems Inc. Aushon BioSystems raises $8.3mm through its Series C venture round Microarray instruments developer Aushon BioSystems Inc. has raised $8.3mm through

Scrip

Start-Up Execs On The Move, November 2012

 
• By Regina Paleski

Start-Up Execs Caprotec bioanalytics GMBH Jonathan Turner, PhD To:Managing Dir. & CEO (October) From:SVP, XL Techgroup Tel:+49 30 63 92 39 90 Cebix Inc. Joel Martin, PhD To:Pres. & CEO (October)

Scrip

Laureate signs antibody deal with Tolera

 
• By Simon Varcoe

Laureate Pharma has signed a contract manufacturing agreement for Tolera Therapeutics ' TOL101 monoclonal antibody under cGMP conditions to be used in clinical trials. TOL101 has demonstrated safet